아토피성 피부염을 가진 조종사의 판정 증례보고
Case Report of a Pilot with Atopic Dermatitis
Aeromedical Center, Korean Air, Seoul, KoreaCorrespondence to:
Received: July 24, 2021; Revised: August 5, 2021; Accepted: August 12, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Korean J Aerosp Environ Med 2021; 31(2): 54-56
Published August 31, 2021 https://doi.org/10.46246/KJAsEM.210011
Copyright © Aerospace Medical Association of Korea.
Atopic dermatitis is a condition that makes skin red and itchy. It is common in children but can occur at any age. Atopic dermatitis is chronic and tends to flare periodically. The pathogenesis of the disease has not yet been clearly elucidated but genetic predisposition, immunological dysfunction, and environmental factors are presumed to be involved in the pathogenesis. In general, it is difficult to cure, but as time passes, most of them heal naturally and the symptoms disappear, but the symptoms continue to recur. So, the basic treatment is to relieve the pruritus and prevent it from reoccurring. Treatment involves avoiding things that make the condition worse, daily bathing with application of moisturizing cream afterwards, applying steroid creams when flares occur, and medications to relieve itching sensation. Steroid pills or creams based on calcineurin inhibitors may occasionally be used if other measures are not effective. When examining a pilot with atopic dermatitis, the dermatitis condition, the treatment being used, and the side effects of the medications should be considered. This case involves an otherwise healthy applicant for the 1st class medical certification who has had atopic dermatitis.
Atopic dermatitis, Aerospace medicine, Certification, Dupilumab
- De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 2012;132(3 Pt 2):949-963. https://doi.org/10.1038/jid.2011.435
- Gittler JK, Shemer A, Suárez-Fariñas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130:1344-1354. https://doi.org/10.1016/j.jaci.2012.07.012
- Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:2455-2466. https://doi.org/10.1056/NEJMoa1304048
- Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014;371:130-139. https://doi.org/10.1056/NEJMoa1314768
- Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 2018;78(3 Suppl 1):S28-S36. https://doi.org/10.1016/j.jaad.2017.12.022
- International Civil Aviation Organization. Manual of civil aviation medicine. 3rd ed. Montréal: International Civil Aviation Organization; 2012.
- Federal Aviation Administration. Guide for aviation medical examiners [Internet]. Washington, D.C.: U.S. Department of Transportation, Federal Aviation Administration; 2021 [updated 2021 Jul 28; cited 2021 Jul 17]. Available from: www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/.